Phosphono/biaryl substituted dipeptide derviatives
CA 2067592 A1 · Owner: Erion, Mark D. · Inventors: Erion, Mark D.; De Lombaert, Stephane
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Phosphono/biaryl substituted dipeptide derivatives Abtract of the Disclosure, Novel N-phosphonomethyl-biaryl substituted dipeptide derivatives of forrnula I wherein R and R' represent independently hydrogen carbocyclic aryl, 6-tetrahydronaphthyl 5-indanyl, acyloxymethyl or acyloxymethyl monosubstituted on methyl carbon by C1-C20-alkyl, by C5-C7-cycloalkyl by aryl or by aryl-lower alkyl; A, represents a direct bond lower alkylene, phenylene or cyclohexylene; m represents I or zero, provided that m represents 1 when A is a direct bond; R1 represents phenyl phenyl, substituted by one to three substituents selected from lower alkyl hydroxy, lower alkoxy, lower alkanoyloxy halogen, cyano, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 29, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 29, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 29, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.